Ocugen, Inc. - FORM 10-K - EX-21.1 - March 18, 2021

Attached files

file filename
EX-3.5 - EX-3.5 - Ocugen, Inc.ocgn-20201231x10kxex35.htm
EX-23.1 - EX-23.1 - Ocugen, Inc.ocgn-20201231x10kxex231.htm
EX-10.12 - EX-10.12 - Ocugen, Inc.ocgn-20201231x10kxex1012.htm
EX-31.2 - EX-31.2 - Ocugen, Inc.ocgn-20201231x10kxex312.htm
EX-4.8 - EX-4.8 - Ocugen, Inc.ocgn-20201231x10kxex48.htm
EX-4.1 - EX-4.1 - Ocugen, Inc.ocgn-20201230x10kxex41.htm
EX-10.7 - EX-10.7 - Ocugen, Inc.ocgn-20201231x10kxex107.htm
EX-31.1 - EX-31.1 - Ocugen, Inc.ocgn-20201231x10kxex311.htm
EX-32.1 - EX-32.1 - Ocugen, Inc.ocgn-20201231x10kxex321.htm
10-K - 10-K - Ocugen, Inc.ocgn-20201231.htm

Exhibit 21.1
Ocugen, Inc.
List of Subsidiaries
Name of Wholly-Owned SubsidiaryJurisdiction of Organization
Ocugen LimitedIreland
Ocugen OpCo, Inc.Delaware
Histogenics Securities CorporationMassachusetts


Ocugen, Inc. Reports